Search Within

David Hyman

  1. "Martee Hensley"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (7)
  3. Book Section (1)
Groups
  1. Department of Medicine (18)
  2. Early Drug Development Service (18)
  3. GDMT, Medicine (18)
  4. Gynecologic Medicine Service (18)
  5. Gynecology Disease Management Team (18)
  6. Solid Tumor Oncology Division (18)

More Groups

People
  1. Martee Hensley (18)
  2. Carol Aghajanian (12)
  3. Rachel Grisham (12)
  4. Roisin O'Cearbhaill (11)
  5. William Tew (10)
  6. Paul Sabbatini (9)

More People

Years
  1. 2021 (1)
  2. 2020 (3)
  3. 2019 (1)
  4. 2018 (3)
  5. 2017 (3)
  6. 2015 (3)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Clinical Cancer Research (2)
  3. Gynecologic Oncology (2)
  4. American Journal of Surgical Pathology (1)
  5. Cancer (1)
  6. Current Opinion in Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (7)
  2. American Association for Cancer Research (3)
  3. Lippincott Williams & Wilkins (3)
  4. Elsevier B.V. (2)
  5. Springer (1)
  6. Wiley Blackwell (1)

More Publishers

Results (18)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2 study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group study 0231D
    Journal Article

    Hyman, D. M.; Sill, M. W.; Lankes, H. A.; Piekarz, R.; Shahin, M. S.; Ridgway, M. R.; Backes, F.; Tenney, M. E.; Mathews, C. A.; Hoffman, J. S.; more...
    Gynecologic Oncology (2017)

    Fulltext@MSK | Save
  • Identifying actionable mutations in uterine leiomyosarcoma
    Meeting Abstract

    Soumerai, T.; Hyman, D. M.; Murali, R.; Zehir, A.; O'Cearbhaill, R. E.; Arcila, M. E.; Aghajanian, C.; Soslow, R. A.; Solit, D. B.; Hensley, M. L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Carboplatin hypersensitivity reactions (HSR) in carboplatin retreatment for recurrent ovarian cancer
    Meeting Abstract

    O'Cearbhaill, R. E.; Hyman, D. M.; Tew, W. P.; Iasonos, A.; Cangemi, N. A.; Aghajanian, C.; Bell-Mcguinn, K. M.; Makker, V.; Hensley, M. L.; Konner, J. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase II study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-0231D)
    Meeting Abstract

    Hyman, D. M.; Sill, M.; Cho, J. K.; Lankes, H. A.; Piekarz, R.; Hensley, M. L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Gynecologic malignancies
    Book Section

    Eng, J.; O'cearbhaill, R.; Litvak, A.; Grisham, R. N.; Hensley, M. L.; Smith, M.; Hyman, D. M.; Tew, W. P.; Meisel, J. L.
    In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

    Fulltext@MSK | Save
  • Management of advanced uterine leiomyosarcoma
    Journal Article

    Hyman, D. M.; Grisham, R. N.; Hensley, M. L.
    Current Opinion in Oncology (2014)

    Fulltext@MSK | Save
  • Nomogram to predict cycle-one serious drug-related toxicity in phase I oncology trials
    Journal Article

    Hyman, D. M.; Eaton, A. A.; Gounder, M. M.; Smith, G. L.; Pamer, E. G.; Hensley, M. L.; Spriggs, D. R.; Ivy, P.; Iasonos, A.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase i clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma
    Journal Article

    Konner, J.; Grisham, R. N.; Park, J.; O'Connor, O. A.; Cropp, G.; Johnson, R.; Hannah, A. L.; Hensley, M. L.; Sabbatini, P.; Mironov, S.; more...
    Investigational New Drugs (2012)

    Fulltext@MSK | Save